Skip to main content
. 2020 Feb 19;7(1):e001200. doi: 10.1136/openhrt-2019-001200

Table 4.

Significant comorbidities discovered in participants with NT-proBNP ≥900 on clinical examination

Number Comorbidity NT-proBNP (ng/L) Measure
1 Severe aortic stenosis 1015 Aortic valve replacement
2 Severe aortic stenosis 1200 Aortic valve replacement
3 Moderate aortic stenosis 2500 Follow-up
4 Severe aortic regurgitation 940 Aortic valve replacement
5 Moderate aortic regurgitation 3936 Follow-up
6 Sick sinus syndrome 1010 Pacemaker
7 Sick sinus syndrome 2133 Pacemaker
8 Hypertrophic obstructive cardiomyopathy 1200 Follow-up
9 Severe chronic renal failure* 3258 Dialysis
10 Amyloidosis 1400 Follow-up
11 Amyloidosis 912 Follow-up
12 Amyloidosis 1917 Follow-up
13 Angina pectoris with significant ischaemic coronary heart disease 1000 PCI of significant LAD stenosis

*Glomerular filtration rate <10 mL/min.

LAD, left anterior descending coronary artery; NT-proBNP, N-terminal pro-B-type natriuretic peptide; PCI, percutaneous coronary intervention.